파킨슨병의 뇌심부자극 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Deep Brain Stimulation In Parkinson's Disease Market Growth & Trends:

The global deep brain stimulation in Parkinson's disease market size is anticipated to reach USD 1.61 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 10.1% from 2025 to 2030. Surge in the incidence of Parkinson's Disease (PD) and growing awareness about the deep brain stimulation in PD are driving the market.

Rising prevalence of Parkinson's disease has raised the demand for deep brain stimulators as an alternative therapy. Deep brain stimulation has been proved to play an important role in providing therapeutic solutions for the symptoms of Parkinson's disease, which is expected to fuel the market growth during the forecast period.

Moreover, increasing demand for minimally invasive therapies due to improved patient outcomes is a high impact rendering driver for this market. This is due to high cost efficiency, minimal pain, safety, short duration of hospital stays, speedy recovery, and few cases of post-surgical problems. These key factors are anticipated to raise the demand for deep brain stimulators over the forecast period.

In addition, technological advancements by the key players for the improved postoperative outcomes and reduced adverse effects in the treatment of PD symptoms are anticipated to raise the demand for deep brain stimulation. For instance, in January 2020, Abbott's Infinity deep brain stimulation system has secured expanded indication approval from the FDA for the treatment of PD. This system will allow to target patients' specific area of the brain called internal globus pallidus (GPi), which is associated with Parkinson's disease symptoms.

Deep Brain Stimulation In Parkinson's Disease Market Report Highlights:

• The dual channel segment dominated the market with the share of 56.9% in 2024 owing to its increasing adoption by neurosurgeons as it is highly effective in reducing patient tremors
• On the basis of end-use, hospitals dominated the market in 2024 since deep brain stimulation procedures are the most complicated and critical surgeries that are performed in hospitals due to availability of high quality and durable equipment
• North America dominated the market with in 2024 owing to prevalence of psychological disorders and presence of well-established healthcare facilities in the region.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources & Third-Party Perspectives
  • 1.3.4. Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Data Visualization
• 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

• 2.1. Market Insights
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. Deep Brain Stimulation In Parkinson's Disease Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Deep Brain Stimulation In Parkinson's Disease Market: Product Outlook Estimates & Forecasts

• 4.1. Deep Brain Stimulation In Parkinson's Disease Market: Product Movement Analysis, 2024 & 2030
  • 4.1.1. Single-channel
    • 4.1.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.1.2. Dual-channel
    • 4.1.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5. Deep Brain Stimulation In Parkinson's Disease Market: End Use Outlook Estimates & Forecasts

• 5.1. Deep Brain Stimulation In Parkinson's Disease Market: End Use Movement Analysis, 2024 & 2030
  • 5.1.1. Hospitals
    • 5.1.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.1.2. Neurology Clinics
    • 5.1.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.1.3. Ambulatory Surgical Centers
    • 5.1.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.1.4. Research Centers
    • 5.1.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. Deep Brain Stimulation In Parkinson's Disease Market Regional Outlook Estimates & Forecasts

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.4. North America
  • 6.4.1. North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. U.S.
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework
    • 6.4.2.3. Competitive insights
    • 6.4.2.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. Canada
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework
    • 6.4.3.3. Competitive insights
    • 6.4.3.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. Mexico
    • 6.4.4.1. Key country dynamics
    • 6.4.4.2. Regulatory framework
    • 6.4.4.3. Competitive insights
    • 6.4.4.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.5. Europe
  • 6.5.1. Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. Germany
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive insights
    • 6.5.2.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. UK
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework
    • 6.5.3.3. Competitive insights
    • 6.5.3.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. Italy
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework
    • 6.5.4.3. Competitive insights
    • 6.5.4.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. France
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework
    • 6.5.5.3. Competitive insights
    • 6.5.5.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.6. Italy
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework
    • 6.5.6.3. Competitive insights
    • 6.5.6.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.7. Spain
    • 6.5.7.1. Key country dynamics
    • 6.5.7.2. Regulatory framework
    • 6.5.7.3. Competitive insights
    • 6.5.7.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.8. Denmark
    • 6.5.8.1. Key country dynamics
    • 6.5.8.2. Regulatory framework
    • 6.5.8.3. Competitive insights
    • 6.5.8.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.9. Sweden
    • 6.5.9.1. Key country dynamics
    • 6.5.9.2. Regulatory framework
    • 6.5.9.3. Competitive insights
    • 6.5.9.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.10. Norway
    • 6.5.10.1. Key country dynamics
    • 6.5.10.2. Regulatory framework
    • 6.5.10.3. Competitive insights
    • 6.5.10.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. China
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Competitive insights
    • 6.6.2.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. Japan
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework
    • 6.6.3.3. Competitive insights
    • 6.6.3.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. India
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework
    • 6.6.4.3. Competitive insights
    • 6.6.4.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. Indonesia
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Regulatory framework
    • 6.6.5.3. Competitive insights
    • 6.6.5.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. South Korea
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Regulatory framework
    • 6.6.6.3. Competitive insights
    • 6.6.6.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Thailand
    • 6.6.7.1. Key country dynamics
    • 6.6.7.2. Regulatory framework
    • 6.6.7.3. Competitive insights
    • 6.6.7.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.8. Australia
    • 6.6.8.1. Key country dynamics
    • 6.6.8.2. Regulatory framework
    • 6.6.8.3. Competitive insights
    • 6.6.8.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.9. Philippines
    • 6.6.9.1. Key country dynamics
    • 6.6.9.2. Regulatory framework
    • 6.6.9.3. Competitive insights
    • 6.6.9.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.10. Malaysia
    • 6.6.10.1. Key country dynamics
    • 6.6.10.2. Regulatory framework
    • 6.6.10.3. Competitive insights
    • 6.6.10.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.11. Singapore
    • 6.6.11.1. Key country dynamics
    • 6.6.11.2. Regulatory framework
    • 6.6.11.3. Competitive insights
    • 6.6.11.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7.2. Brazil
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework
    • 6.7.2.3. Competitive insights
    • 6.7.2.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. Argentina
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework
    • 6.7.3.3. Competitive insights
    • 6.7.3.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7.4. Colombia
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework
    • 6.7.4.3. Competitive insights
    • 6.7.4.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7.5. Chile
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Regulatory framework
    • 6.7.5.3. Competitive insights
    • 6.7.5.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7.6. Venezuela
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Regulatory framework
    • 6.7.6.3. Competitive insights
    • 6.7.6.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.8. Middle East & Africa
  • 6.8.1. MEA market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8.2. South Africa
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework
    • 6.8.2.3. Competitive insights
    • 6.8.2.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key country dynamics
    • 6.8.3.2. Regulatory framework
    • 6.8.3.3. Competitive insights
    • 6.8.3.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8.4. UAE
    • 6.8.4.1. Key country dynamics
    • 6.8.4.2. Regulatory framework
    • 6.8.4.3. Competitive insights
    • 6.8.4.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8.5. Turkey
    • 6.8.5.1. Key country dynamics
    • 6.8.5.2. Regulatory framework
    • 6.8.5.3. Competitive insights
    • 6.8.5.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8.6. Iran
    • 6.8.6.1. Key country dynamics
    • 6.8.6.2. Regulatory framework
    • 6.8.6.3. Competitive insights
    • 6.8.6.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8.7. Kuwait
    • 6.8.7.1. Key country dynamics
    • 6.8.7.2. Regulatory framework
    • 6.8.7.3. Competitive insights
    • 6.8.7.4. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Vendor Landscape
  • 7.2.1. Company categorization
  • 7.2.2. List of Key Distributors and Channel Partners
  • 7.2.3. List of Potential Customers/End Users
• 7.3. Competitive Dynamics
  • 7.3.1. Competitive Benchmarking
  • 7.3.2. Strategy Mapping
  • 7.3.3. Heat Map Analysis
• 7.4. Company Profiles/Listing
  • 7.4.1. ABBOTT
    • 7.4.1.1. Participant's overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Medtronic
    • 7.4.2.1. Participant's overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Boston Scientific Corporation
    • 7.4.3.1. Participant's overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives